SCHW NYSE Investment Banking & Brokerage Financials FY2016–FY2025
Charles Schwab is a savings and loan holding company that runs a brokerage, a bank, and asset management, custody and advisory businesses. At the end of 2025 it had $11.90 trillion in client assets, 38.5 million active brokerage accounts, 5.7 million workplace plan participant accounts and 2.2 million banking accounts.
Hi! I read Charles Schwab’s latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+22.0%
Yes. Sales grew 22.0% last year.
Does it make a profit?
37.0%
Yes. It keeps 37.0% of every sale as profit.
How lean are its costs?
52.1%
Lean. Running costs take 52.1% of revenue.
How much does it earn on its capital?
18.1%
Good. It earns 18.1% a year on shareholders’ money.
How is the share priced?
16.3x
One share costs 16.3 times its yearly profit per share. Typical for its sector: 13.7x.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA · Charles Schwab had $23.9B of revenue in fiscal 2025, up 22.0% on the year before. Over five years, revenue changed +15.4% a year on average.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Net interest income share and efficiency ratio
Net interest income share and efficiency ratio
KIRA · Charles Schwab made $8.9B of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 15.1% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA · Charles Schwab returned $9.7B to shareholders in fiscal 2025. The diluted share count fell 1.4%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA · In the last 12 months, insiders bought $1.8M and sold $335M of shares on the open market.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$1.8M
1 insider
Sold, 12 months
$335M
15 insiders
Of sales under plans
11%
$35.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Neesha HathiMD, Head Wealth Adv, Bnk, Tst | Sold plan | 5,000 | $97.80 | $0.5M | Form 4 |
| Sep 1, 2026 | Neesha HathiMD, Head Wealth Adv, Bnk, Tst | Sold plan | 3,177 | $109.04 | $0.3M | Form 4 |
| Aug 28, 2026 | Walter W BettingerCo-Chairman, Director | Sold | 74,388 | $110.91 | $8.3M | Form 4 |
| Aug 28, 2026 | Neesha HathiMD, Head Wealth Adv, Bnk, Tst | Sold plan | 3,177 | $108.12 | $0.3M | Form 4 |
| Aug 26, 2026 | Carolyn Schwab-PomerantzDirector | Sold | 9,175 | $109.25 | $1.0M | Form 4 |
| Aug 24, 2026 | Walter W BettingerCo-Chairman, Director | Sold | 176,210 | $113.49 | $20.0M | Form 4 |
| Aug 24, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 117,000 | $113.20 | $13.2M | Form 4 |
| Aug 17, 2026 | Jonathan S BeattyMD, Head of Advisor Services | Sold | 1,000 | $111.33 | $0.1M | Form 4 |
| Aug 14, 2026 | Jonathan M. CraigMD, Head of Retail Investing | Sold plan | 21,866 | $111.03 | $2.4M | Form 4 |
| Aug 13, 2026 | Dennis HowardMD, Chief Tech, OPS & Data Off | Sold plan | 2,198 | $110.00 | $0.2M | Form 4 |
| Aug 12, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 46,410 | $108.18 | $5.0M | Form 4 |
| Aug 11, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 46,445 | $107.78 | $5.0M | Form 4 |
| Aug 10, 2026 | Nigel J MurtaghChief Risk Officer | Sold plan | 24,778 | $109.01 | $2.7M | Form 4 |
| Aug 7, 2026 | Paula A SneedDirector | Sold | 5,263 | $107.15 | $0.6M | Form 4 |
| Aug 6, 2026 | Nigel J MurtaghChief Risk Officer | Sold plan | 1,897 | $109.00 | $0.2M | Form 4 |
| Aug 5, 2026 | Carolyn Schwab-PomerantzDirector | Sold | 18,561 | $107.70 | $2.0M | Form 4 |
| Aug 5, 2026 | Jonathan M. CraigMD, Head of Retail Investing | Sold plan | 21,750 | $107.02 | $2.3M | Form 4 |
| Aug 4, 2026 | Carolyn Schwab-PomerantzDirector | Sold | 22,640 | $106.36 | $2.4M | Form 4 |
| Aug 4, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 47,650 | $106.08 | $5.1M | Form 4 |
| Aug 3, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 95,250 | $105.52 | $10.1M | Form 4 |
| Jul 29, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 95,450 | $105.82 | $10.1M | Form 4 |
| Jul 28, 2026 | Carolyn Schwab-PomerantzDirector | Sold | 22,650 | $105.71 | $2.4M | Form 4 |
| Jul 28, 2026 | Dennis HowardMD, Chief Tech, OPS & Data Off | Sold plan | 28,000 | $105.01 | $2.9M | Form 4 |
| Jul 28, 2026 | Walter W BettingerCo-Chairman, Director | Sold | 93,408 | $104.64 | $9.8M | Form 4 |
| Jul 28, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 48,000 | $105.60 | $5.1M | Form 4 |
| Jul 27, 2026 | Nigel J MurtaghChief Risk Officer | Sold plan | 32,947 | $104.01 | $3.4M | Form 4 |
| Jul 27, 2026 | Walter W BettingerCo-Chairman, Director | Sold | 192,488 | $103.90 | $20.0M | Form 4 |
| Jul 24, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 45,500 | $101.72 | $4.6M | Form 4 |
| Jul 23, 2026 | Peter J. Morgan IIIGeneral Counsel | Sold | 6,952 | $102.03 | $0.7M | Form 4 |
| Jul 21, 2026 | Nigel J MurtaghChief Risk Officer | Sold plan | 4,053 | $104.14 | $0.4M | Form 4 |
| Jul 21, 2026 | Jonathan S BeattyMD, Head of Advisor Services | Sold plan | 2,000 | $104.21 | $0.2M | Form 4 |
| Jul 7, 2026 | Jonathan S BeattyMD, Head of Advisor Services | Sold plan | 2,000 | $102.01 | $0.2M | Form 4 |
| Jul 7, 2026 | Jonathan M. CraigMD, Head of Retail Investing | Sold plan | 21,750 | $102.01 | $2.2M | Form 4 |
| Jul 6, 2026 | Jonathan S BeattyMD, Head of Advisor Services | Sold plan | 2,000 | $100.01 | $0.2M | Form 4 |
| Jul 2, 2026 | Jonathan S BeattyMD, Head of Advisor Services | Sold plan | 2,000 | $97.03 | $0.2M | Form 4 |
| May 28, 2026 | Richard A WursterPresident & CEO, Director | Bought | 21,959 | $84.23 | $1.8M | Form 4 |
| May 19, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 27,500 | $92.22 | $2.5M | Form 4 |
| May 18, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 27,500 | $92.40 | $2.5M | Form 4 |
| May 13, 2026 | Arun SarinDirector | Sold | 2,500 | $91.16 | $0.2M | Form 4 |
| May 6, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 109,300 | $92.01 | $10.1M | Form 4 |
| May 5, 2026 | Carolyn Schwab-PomerantzDirector | Sold | 9,910 | $92.29 | $0.9M | Form 4 |
| May 4, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 109,300 | $91.50 | $10.0M | Form 4 |
| May 1, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 55,000 | $91.86 | $5.1M | Form 4 |
| Apr 30, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 50,000 | $91.81 | $4.6M | Form 4 |
| Apr 29, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 63,743 | $90.49 | $5.8M | Form 4 |
| Apr 28, 2026 | Frank C HerringerDirector | Sold | 2,520 | $90.60 | $0.2M | Form 4 |
| Apr 27, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 36,450 | $90.00 | $3.3M | Form 4 |
| Apr 23, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 36,450 | $90.50 | $3.3M | Form 4 |
| Apr 15, 2026 | Paul Woolway VMD, Chief Banking Officer | Sold plan | 7,941 | $100.00 | $0.8M | Form 4 |
| Apr 14, 2026 | Jonathan M. CraigMD, Head of Retail Investing | Sold plan | 21,750 | $99.00 | $2.2M | Form 4 |
| Apr 14, 2026 | Paul Woolway VMD, Chief Banking Officer | Sold plan | 7,942 | $98.00 | $0.8M | Form 4 |
| Apr 14, 2026 | Nigel J MurtaghChief Risk Officer | Sold plan | 41,297 | $99.00 | $4.1M | Form 4 |
| Mar 3, 2026 | Dennis HowardMD, Chief Tech, OPS & Data Off | Sold plan | 10,108 | $94.60 | $1.0M | Form 4 |
| Mar 3, 2026 | Nigel J MurtaghChief Risk Officer | Sold plan | 7,203 | $94.61 | $0.7M | Form 4 |
| Mar 3, 2026 | Paul Woolway VMD, Chief Banking Officer | Sold plan | 6,126 | $94.61 | $0.6M | Form 4 |
| Mar 3, 2026 | Jonathan M. CraigMD, Head of Investor Services | Sold plan | 14,481 | $94.60 | $1.4M | Form 4 |
| Mar 2, 2026 | Paul Woolway VMD, Chief Banking Officer | Sold plan | 15,884 | $95.12 | $1.5M | Form 4 |
| Feb 27, 2026 | Jonathan S BeattyMD, Head of Advisor Services | Sold | 2,030 | $95.30 | $0.2M | Form 4 |
| Feb 26, 2026 | Stephen A EllisDirector | Sold | 10,725 | $96.57 | $1.0M | Form 4 |
| Feb 25, 2026 | Dennis HowardMD, Chief Tech, OPS & Data Off | Sold plan | 27,903 | $95.02 | $2.7M | Form 4 |
| Feb 10, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 32,413 | $105.58 | $3.4M | Form 4 |
| Feb 9, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 126,200 | $106.55 | $13.4M | Form 4 |
| Feb 6, 2026 | Walter W BettingerCo-Chairman, Director | Sold | 67,514 | $104.25 | $7.0M | Form 4 |
| Feb 6, 2026 | Christopher Dodds VDirector | Sold | 11,825 | $104.55 | $1.2M | Form 4 |
| Feb 4, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 67,975 | $103.81 | $7.1M | Form 4 |
| Feb 4, 2026 | Walter W BettingerCo-Chairman, Director | Sold | 94,948 | $104.25 | $9.9M | Form 4 |
| Feb 3, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 96,625 | $103.74 | $10.0M | Form 4 |
| Feb 3, 2026 | Walter W BettingerCo-Chairman, Director | Sold | 162,462 | $103.90 | $16.9M | Form 4 |
| Feb 2, 2026 | Peter J. Morgan IIIGeneral Counsel | Sold | 7,595 | $104.38 | $0.8M | Form 4 |
| Jan 29, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 145,650 | $103.16 | $15.0M | Form 4 |
| Jan 28, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 71,437 | $103.21 | $7.4M | Form 4 |
| Jan 26, 2026 | Charles R. SchwabCo-Chairman, Director | Sold | 134,895 | $103.09 | $13.9M | Form 4 |
| Jan 22, 2026 | Carolyn Schwab-PomerantzDirector | Sold | 42,865 | $105.20 | $4.5M | Form 4 |
| Jan 22, 2026 | Jonathan S BeattyMD, Head of Advisor Services | Sold plan | 2,000 | $105.00 | $0.2M | Form 4 |
| Dec 23, 2025 | Jonathan S BeattyMD, Head of Advisor Services | Sold plan | 2,000 | $102.01 | $0.2M | Form 4 |
| Nov 12, 2025 | Jonathan S BeattyMD, Head of Advisor Services | Sold plan | 3,072 | $98.00 | $0.3M | Form 4 |
| Nov 7, 2025 | Jonathan M. CraigMD, Head of Investor Services | Sold | 35,188 | $95.35 | $3.4M | Form 4 |
| Oct 29, 2025 | Charles R. SchwabCo-Chairman, Director | Sold | 44,750 | $94.52 | $4.2M | Form 4 |
| Oct 28, 2025 | Charles R. SchwabCo-Chairman, Director | Sold | 64,400 | $94.00 | $6.1M | Form 4 |
| Oct 2, 2025 | Carolyn Schwab-PomerantzDirector | Sold plan | 24,000 | $92.55 | $2.2M | Form 4 |
| Oct 1, 2025 | Paul Woolway VMD, Chief Banking Officer | Sold plan | 3,205 | $93.32 | $0.3M | Form 4 |
Can it carry its debts, and how well does it use its money?
Loans, deposits and capital at each fiscal year end.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Loans and deposits
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Loans, net | $34.6B | $40.5B | $40.4B | $45.2B | $58.0B |
| Deposits | $443.8B | $366.7B | $290.0B | $259.1B | $255.7B |
| Loans / deposits | 7.8% | 11.1% | 14.0% | 17.5% | 22.7% |
| Total assets | $667.3B | $551.8B | $493.2B | $479.8B | $491.0B |
| Shareholders' equity | $56.3B | $36.6B | $41.0B | $48.4B | $49.4B |
| Goodwill | $12.0B | $12.0B | $12.0B | $12.0B | $12.0B |
| Intangible assets | $9.4B | $8.8B | $8.3B | $7.7B | $7.2B |
| Provision / loans | −0.0% | 0.2% | −0.1% | −0.0% | 0.0% |
KIRA · It earned 18.1% on shareholders’ money. Running costs took 52.1% of revenue (the efficiency ratio; lower is better).
For banks, return on equity and the efficiency ratio (costs as a share of revenue) say most about how well the business runs.
In plain words: Return on equity is the profit made on shareholders’ money each year. The efficiency ratio is how much of each dollar of revenue goes on running costs, so lower is better.
Return on equity, return on tangible equity and efficiency ratio
What does the share cost, and how does it compare?
KIRA · At $89.73 a share, the company is worth $162.3B: 16.3 times its earnings of the last four quarters.
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
In plain words: Move the sliders to try your own guesses about growth. The result is what one share would be worth if those guesses came true. Different guesses give very different answers.
Value per share
—
Reference multiples: today 16.5x · peers 13.6x · sector 13.7x.
KIRA · Charles Schwab grew sales faster than 4 of its 4 similar companies. Its P/E is higher than 4 of 4.
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
In plain words: The same numbers for similar companies, so you can tell whether a figure is high or low for this kind of business.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Charles Schwab SCHW | $162.3B | 22.0% | — | — | — | 16.3x | — | |
| Raymond James Financial RJF | $32.7B | 6.6% | — | — | — | 13.8x | — | Compare → |
| Goldman Sachs GS | $283.7B | 8.9% | — | — | — | 13.8x | — | Compare → |
| Morgan Stanley MS | $292.1B | 14.4% | — | — | — | 14.8x | — | Compare → |
| Stifel SF | $7.3B | 6.7% | — | — | — | 11.9x | — | Compare → |
Every number, year by year.
Amounts in USD. Hover a ratio’s name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $7.5B | $8.6B | $10.1B | $10.7B | $11.7B | $18.5B | $20.8B | $18.8B | $19.6B | $23.9B |
| Net interest income | $3.3B | $4.3B | $5.8B | $6.5B | $6.1B | $8.0B | $10.7B | $9.4B | $9.1B | $11.8B |
| Noninterest expense | $4.5B | $5.0B | $5.6B | $5.9B | $7.4B | $10.8B | $11.4B | $12.5B | $11.9B | $12.5B |
| Provision for credit losses | −$5.0M | $0.0M | −$6.0M | −$5.0M | $10.0M | −$12.0M | $58.0M | −$35.0M | −$17.0M | $15.0M |
| Pretax income | $3.0B | $3.7B | $4.6B | $4.8B | $4.3B | $7.7B | $9.4B | $6.4B | $7.7B | $11.5B |
| Income tax | $1.1B | $1.3B | $1.1B | $1.1B | $1.0B | $1.9B | $2.2B | $1.3B | $1.8B | $2.6B |
| Net income | $1.9B | $2.4B | $3.5B | $3.7B | $3.3B | $5.9B | $7.2B | $5.1B | $5.9B | $8.9B |
| Net income to common | $1.7B | $2.2B | $3.3B | $3.5B | $3.0B | $5.4B | $6.6B | $4.6B | $5.5B | $8.4B |
| Diluted EPS | $1.31 | $1.61 | $2.45 | $2.67 | $2.12 | $2.83 | $3.50 | $2.54 | $2.99 | $4.65 |
| Diluted shares | 1.33B | 1.35B | 1.36B | 1.32B | 1.44B | 1.90B | 1.89B | 1.83B | 1.83B | 1.81B |
| Cash flow | ||||||||||
| Stock-based compensation | $141M | $153M | $197M | $183M | $204M | $254M | $366M | $320M | $337M | $317M |
| Share buybacks | $0.0M | $0.0M | $1.0B | $2.2B | $0.0M | $0.0M | $3.4B | $2.8B | $0.0M | $7.3B |
| Dividends paid | $486M | $592M | $787M | $1.1B | $1.3B | $1.8B | $2.1B | $2.3B | $2.3B | $2.3B |
| Dividends and buybacks | $486M | $592M | $1.8B | $3.3B | $1.3B | $1.8B | $5.5B | $5.1B | $2.3B | $9.7B |
| Balance sheet | ||||||||||
| Loans, net | $15.4B | $16.5B | $16.6B | $18.2B | $23.8B | $34.6B | $40.5B | $40.4B | $45.2B | $58.0B |
| Deposits | $163.5B | $169.7B | $231.4B | $220.1B | $358.0B | $443.8B | $366.7B | $290.0B | $259.1B | $255.7B |
| Goodwill | $1.2B | $1.2B | $1.2B | $1.2B | $12.0B | $12.0B | $12.0B | $12.0B | $12.0B | $12.0B |
| Intangible assets | $144M | $108M | $152M | $128M | $10.0B | $9.4B | $8.8B | $8.3B | $7.7B | $7.2B |
| Total assets | $223.4B | $243.3B | $296.5B | $294.0B | $549.0B | $667.3B | $551.8B | $493.2B | $479.8B | $491.0B |
| Preferred stock | $2.8B | $2.8B | $2.8B | $2.8B | $7.7B | $10.0B | $9.7B | $9.2B | $9.2B | $6.8B |
| Shareholders' equity | $16.4B | $18.5B | $20.7B | $21.7B | $56.1B | $56.3B | $36.6B | $41.0B | $48.4B | $49.4B |
| Margins | ||||||||||
| Net margin | 25.3% | 27.3% | 34.6% | 34.6% | 28.2% | 31.6% | 34.6% | 26.9% | 30.3% | 37.0% |
| Net interest share of revenue | 44.4% | 49.7% | 57.5% | 60.8% | 52.3% | 43.4% | 51.5% | 50.1% | 46.6% | 49.1% |
| Efficiency ratio | 60.0% | 57.7% | 55.0% | 54.8% | 63.2% | 58.4% | 54.8% | 66.1% | 60.8% | 52.1% |
| Returns | ||||||||||
| Return on equity | 12.7% | 13.5% | 17.9% | 17.5% | 8.5% | 10.4% | 15.5% | 13.1% | 13.3% | 18.1% |
| Return on assets | 0.9% | 1.0% | 1.3% | 1.3% | 0.8% | 1.0% | 1.2% | 1.0% | 1.2% | 1.8% |
| Return on tangible equity | 15.3% | 16.4% | 21.6% | 20.7% | 13.8% | 20.9% | 42.6% | 52.5% | 35.3% | 39.2% |
| Growth | ||||||||||
| Revenue growth | 17.2% | 15.2% | 17.6% | 5.8% | 9.1% | 58.4% | 12.1% | −9.3% | 4.1% | 22.0% |
| Net income growth | 30.6% | 24.6% | 49.0% | 5.6% | −10.9% | 77.5% | 22.7% | −29.5% | 17.3% | 49.0% |
| EPS growth | 27.2% | 22.9% | 52.2% | 9.0% | −20.6% | 33.5% | 23.7% | −27.4% | 17.7% | 55.5% |
| Share count change | 0.5% | 1.4% | 0.6% | −3.0% | 8.7% | 32.2% | −0.2% | −3.3% | 0.2% | −1.4% |
| Financial health | ||||||||||
| Loans / deposits | 9.4% | 9.7% | 7.2% | 8.3% | 6.7% | 7.8% | 11.1% | 14.0% | 17.5% | 22.7% |
| Provision / loans | −0.0% | 0.0% | −0.0% | −0.0% | 0.1% | −0.0% | 0.2% | −0.1% | −0.0% | 0.0% |
| Capital allocation | ||||||||||
| Stock comp / revenue | 1.9% | 1.8% | 1.9% | 1.7% | 1.7% | 1.4% | 1.8% | 1.7% | 1.7% | 1.3% |
Source: SEC EDGAR XBRL filings (CIK 0000316709). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
